Press releases

GSK discloses $28,375 in payments to HCPs

Read more - GSK discloses $28,375 in payments to HCPs Read more

GSK increases supply of Menningococcal B vaccine

Read more - GSK increases supply of Menningococcal B vaccine Read more

New research shows Australians aren’t taking ageing lying down

Read more - New research shows Australians aren’t taking ageing lying down Read more

New treatment option available January 1 2017 for patients with a form of severe asthma

First therapy approved for severe refractory eosinophilic asthma to be listed on the PBS

Read more - New treatment option available January 1 2017 for patients with a form of severe asthma Read more

Santa’s prostate nightmare urges Australian men to act

What would happen to Christmas if Santa suffered prostate issues?

#SeatsUpForSanta social initiative puts spotlight on enlarged prostate symptoms

Read more - Santa’s prostate nightmare urges Australian men to act Read more

GSK leads Access to Medicine Index 2016

GSK tops the Access to Medicines Index for the fifth consecutive time.

Read more - GSK leads Access to Medicine Index 2016 Read more

GSK Consumer Healthcare to close Ermington manufacturing site in 2020

GSK Consumer Healthcare announced that it will close its manufacturing facility at Ermington, in Sydney’s north-west, in 2020. The decision was made after a thorough evaluation of the site, which revealed the manufacturing site would not be able to remain competitive in the long-term.

All entitlements are protected for the 223 employees whose jobs are affected, and the company will work through the next four years to provide support.

Read more - GSK Consumer Healthcare to close Ermington manufacturing site in 2020 Read more

Bexsero® (Meningococcal B) vaccine availability

Read more - Bexsero® (Meningococcal B) vaccine availability Read more